Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections

Chlamydia trachomatis and C. pneumoniae are members of the Chlamydiaceae family of obligate intracellular bacteria. The former causes diseases predominantly at the mucosal epithelial layer of the urogenital or eye, leading to pelvic inflammatory diseases or blindness; while the latter is a major causative agent for pulmonary infection. On top of these well-described diseases at the respective primary infection sites, Chlamydia are notoriously known to migrate and cause pathologies at remote sites of a host. One such example is the sexually acquired reactive arthritis that often occurs at few weeks after genital C. trachomatis infection. C. pneumoniae, on the other hand, has been implicated in an extensive list of chronic inflammatory diseases which include atherosclerosis, multiple sclerosis, Alzheimer’s disease, asthma, and primary biliary cirrhosis. This review summarizes the Chlamydia infection associated diseases at the secondary sites of infection, and describes the potential mechanisms involved in the disease migration and pathogenesis.

[1]  B. Arulanandam,et al.  Chlamydia and Its Many Ways of Escaping the Host Immune System , 2019, Journal of pathogens.

[2]  W. Wong,et al.  Chlamydiaceae: Diseases in Primary Hosts and Zoonosis , 2019, Microorganisms.

[3]  Wei Bi,et al.  Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.

[4]  J. Correale,et al.  The role of infections in multiple sclerosis , 2019, Multiple sclerosis.

[5]  B. Arulanandam,et al.  CPAF, HSP60 and MOMP antigens elicit pro-inflammatory cytokines production in the peripheral blood mononuclear cells from genital Chlamydia trachomatis-infected patients. , 2019, Immunobiology.

[6]  M. Panzetta,et al.  Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo , 2018, Front. Microbiol..

[7]  J. Dagvadorj,et al.  Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis. , 2018, Cell metabolism.

[8]  D. Kell,et al.  The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia , 2018, Front. Aging Neurosci..

[9]  A. Yamamoto,et al.  Intranasal rifampicin for Alzheimer's disease prevention , 2018, Alzheimer's & dementia.

[10]  P. Shah,et al.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. , 2018, Journal of the American College of Cardiology.

[11]  Alzheimer’s Association 2018 Alzheimer's disease facts and figures , 2018, Alzheimer's & Dementia.

[12]  F. Sharp,et al.  Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review , 2018, Front. Aging Neurosci..

[13]  Mark Ellisman,et al.  Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis , 2018, Nature Communications.

[14]  M. Wildung,et al.  Genomewide Transcriptional Responses of Iron-Starved Chlamydia trachomatis Reveal Prioritization of Metabolic Precursor Synthesis over Protein Translation , 2017, mSystems.

[15]  F. Radouani,et al.  Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases. , 2017, Journal of infection and public health.

[16]  D. Hahn,et al.  Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides , 2017, Respiratory Research.

[17]  S. Singh,et al.  Modulation of Inflammation Induced by Recombinant MOMP of Chlamydia in Mouse Macrophages by IL-10 is Mediated by Skewing M1 to an M2 Polarizing Macrophage Phenotype , 2017, The Journal of Immunology.

[18]  H. Ward,et al.  Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. , 2016, The Lancet. Infectious diseases.

[19]  W. Klein,et al.  Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. , 2016, Brain : a journal of neurology.

[20]  B. Arulanandam,et al.  Temporal proteomic profiling of Chlamydia trachomatis–infected HeLa‐229 human cervical epithelial cells , 2016, Proteomics.

[21]  R. Iramain,et al.  Chlamydia pneumoniae, and mycoplasma pneumoniae: Are they related to severe asthma in childhood? , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.

[22]  D. Hahn,et al.  Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? , 2016, The Lancet. Respiratory medicine.

[23]  Anand K. Ramasubramanian,et al.  Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci , 2016, Scientific Reports.

[24]  A. Hudson,et al.  Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research , 2016, Current Rheumatology Reports.

[25]  A. Murthy,et al.  CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. , 2015, Pathogens and disease.

[26]  J. Forrester,et al.  High Chlamydia Burden Promotes Tumor Necrosis Factor–Dependent Reactive Arthritis in SKG Mice , 2015, Arthritis & rheumatology.

[27]  A. Katsambas,et al.  Reactive Arthritis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  D. Appelt,et al.  Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae , 2014, Front. Aging Neurosci..

[29]  H. Haller,et al.  Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells , 2014, BMC Microbiology.

[30]  Michael J. Emanuele,et al.  Chlamydia trachomatis-induced alterations in the host cell proteome are required for intracellular growth. , 2014, Cell host & microbe.

[31]  Kai Yin,et al.  Foam cells in atherosclerosis. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[32]  J. Esdaile,et al.  Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis , 2013, The Journal of Rheumatology.

[33]  S. Yale,et al.  Azithromycin for Bronchial Asthma in Adults: An Effectiveness Trial , 2012, The Journal of the American Board of Family Medicine.

[34]  D. Hahn,et al.  Chlamydia pneumoniae-Specific IgE Is Prevalent in Asthma and Is Associated with Disease Severity , 2012, PloS one.

[35]  N. Hanania,et al.  The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. , 2012, Respiratory medicine.

[36]  K. A. Fields,et al.  Disulfide Bonding within Components of the Chlamydia Type III Secretion Apparatus Correlates with Development , 2011, Journal of bacteriology.

[37]  O. Cissé,et al.  Permissivity of Vero cells, human pneumocytes and human endometrial cells to Waddlia chondrophila. , 2011, Microbes and infection.

[38]  J. Gottenberg,et al.  Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. , 2011, Arthritis and rheumatism.

[39]  J. Rupp,et al.  Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo , 2010, Proceedings of the National Academy of Sciences.

[40]  D. Appelt,et al.  Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain , 2010, BMC Neuroscience.

[41]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[42]  J. Carter,et al.  The pathogenic role of Chlamydia in spondyloarthritis , 2010, Current opinion in rheumatology.

[43]  J. Carter,et al.  Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. , 2010, Arthritis and rheumatism.

[44]  J. Carter Treating reactive arthritis: insights for the clinician , 2010, Therapeutic advances in musculoskeletal disease.

[45]  G. Zummo,et al.  Chlamydia trachomatis Infection and Anti-Hsp60 Immunity: The Two Sides of the Coin , 2009, PLoS pathogens.

[46]  S. Hatachi,et al.  Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases , 2009, Lupus.

[47]  D. Vergani,et al.  Bacteria and Primary Biliary Cirrhosis , 2009, Clinical reviews in allergy & immunology.

[48]  M. McGrath,et al.  Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS) , 2009, Journal of Neuroimmunology.

[49]  G. Schiavoni,et al.  Chlamydia Pneumoniae and Atherosclerosis: Current State and Future Prospectives , 2009, International journal of immunopathology and pharmacology.

[50]  Nicholas J Alp,et al.  Role of Chlamydia pneumoniae in atherosclerosis. , 2008, Clinical science.

[51]  H. Gérard,et al.  Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. , 2008, Microbial pathogenesis.

[52]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[53]  K. Hybiske,et al.  Mechanisms of host cell exit by the intracellular bacterium Chlamydia , 2007, Proceedings of the National Academy of Sciences.

[54]  H. Steinbusch,et al.  Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection , 2007, Acta Neuropathologica.

[55]  H. Steinbusch,et al.  Chlamydia pneumoniae infection of brain cells: An in vitro study , 2007, Neurobiology of Aging.

[56]  J. Treib,et al.  Long-term Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis , 2006, Infection.

[57]  H. Gérard,et al.  Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. , 2006, FEMS immunology and medical microbiology.

[58]  C. Stratton,et al.  Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. , 2006, Trends in microbiology.

[59]  G. Cutter,et al.  Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.

[60]  P. Bagos,et al.  Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis , 2006, Multiple sclerosis.

[61]  M. Hernán,et al.  Antibiotic use and risk of multiple sclerosis. , 2006, American journal of epidemiology.

[62]  F. Blasi,et al.  Chlamydia pneumoniae and Mycoplasma pneumoniae. , 2005, Seminars in respiratory and critical care medicine.

[63]  S. Johnston,et al.  Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? , 2005, American journal of respiratory and critical care medicine.

[64]  D. Virok,et al.  Chlamydial IFN-γ immune evasion is linked to host infection tropism , 2005 .

[65]  R. Zhong,et al.  Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. , 2005, World journal of gastroenterology.

[66]  J. Ager,et al.  The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. , 2005, Microbial pathogenesis.

[67]  P. Leanderson,et al.  Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase- dependent production of reactive oxygen species in platelets , 2005, Thrombosis and Haemostasis.

[68]  P. Salvà,et al.  The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. , 2005, American journal of respiratory and critical care medicine.

[69]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[70]  E. Märker-Hermann,et al.  Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor α and interferon γ , 2004 .

[71]  J. Carter,et al.  Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. , 2004, The Journal of rheumatology.

[72]  H. Zeidler,et al.  Chlamydia-induced arthritis , 2004, Current opinion in rheumatology.

[73]  D. Appelt,et al.  Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice , 2004, Neurobiology of Aging.

[74]  W. Solbach,et al.  Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature For editorial comments see page 499. , 2004, European Respiratory Journal.

[75]  Michael Borrie,et al.  A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer's Disease , 2004, Journal of the American Geriatrics Society.

[76]  S. Ouellette,et al.  Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.

[77]  D. Virok,et al.  Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[78]  HannaKälvegren,et al.  Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation , 2003 .

[79]  T. Bengtsson,et al.  Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease? , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[80]  R. Coppel,et al.  Is there a Relation between Chlamydia Infection and Primary Biliary Cirrhosis? , 2003, Clinical & developmental immunology.

[81]  D. Appelt,et al.  Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells , 2003, Journal of neuroscience research.

[82]  Lisa Chasan-Taber,et al.  Infection with Chlamydia pneumoniae and Risk of Multiple Sclerosis , 2003, Epidemiology.

[83]  D. Appelt,et al.  Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. , 2002, FEMS microbiology letters.

[84]  G. Wilcock,et al.  Failure to correlate C. pneumoniae with late onset Alzheimer's disease. , 2002, Neurology.

[85]  K. Lindor,et al.  Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? , 2002, Journal of hepatology.

[86]  L. V. von Hertzen Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae , 2002, European Respiratory Journal.

[87]  H. Gérard,et al.  Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection , 2001, Molecular microbiology.

[88]  H. Gérard,et al.  A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats1 , 2001, The Journal of Immunology.

[89]  T. Derfuss,et al.  Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. , 2001, Brain : a journal of neurology.

[90]  Yoshimasa Yamamoto,et al.  PCR-Based Method for Isolation and Detection of Chlamydia pneumoniae DNA in Cerebrospinal Fluids , 2001, Clinical Diagnostic Laboratory Immunology.

[91]  F. Hanefeld,et al.  Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis , 2001, Annals of neurology.

[92]  D. Taylor-Robinson,et al.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted? , 2001, Annals of the rheumatic diseases.

[93]  M. Hammerschlag,et al.  Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis? , 2000, Journal of Clinical Microbiology.

[94]  H. Gérard,et al.  Chlamydia pneumoniae present in the human synovium are viable and metabolically active. , 2000, Microbial pathogenesis.

[95]  R. Ring,et al.  Failure To Detect Chlamydia pneumoniaein the Late-Onset Alzheimer's Brain , 2000, Journal of Clinical Microbiology.

[96]  A. Grau,et al.  Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis , 2000, Annals of neurology.

[97]  W. Solbach,et al.  Failure To Detect Chlamydia pneumoniaein Brain Sections of Alzheimer's Disease Patients , 2000, Journal of Clinical Microbiology.

[98]  H. Gérard,et al.  Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. , 1999, Arthritis and rheumatism.

[99]  C. Stratton,et al.  Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis , 1999, Annals of neurology.

[100]  J. Ramirez,et al.  Infection of Human Endothelial Cells with Chlamydia pneumoniae Stimulates Transendothelial Migration of Neutrophils and Monocytes , 1999, Infection and Immunity.

[101]  J. Neuberger,et al.  PBC and AMA—what is the connection? , 1999, Hepatology.

[102]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[103]  L. Campbell,et al.  Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. , 1998, The Journal of infectious diseases.

[104]  J. Ayres,et al.  Chlamydia pneumoniae and asthma , 1998, Thorax.

[105]  C. Stratton,et al.  Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS , 1998, Neurology.

[106]  S. Johnston,et al.  Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. , 1998, The European respiratory journal.

[107]  O. Moling,et al.  Chlamydia pneumoniae--reactive arthritis and persistent infection. , 1996, British journal of rheumatology.

[108]  E. O’Brien,et al.  In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae , 1995, Journal of clinical microbiology.

[109]  Y. Shemer-Avni,et al.  Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. , 1995, The Journal of infectious diseases.

[110]  H. Mori,et al.  Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. , 1994, Biochemical and biophysical research communications.

[111]  W. Beatty,et al.  Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence , 1994, Infection and immunity.

[112]  P. Wu,et al.  Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis. , 1994, Annals of the rheumatic diseases.

[113]  A. Hassell,et al.  Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones. , 1993, Immunology.

[114]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[115]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[116]  J. Schachter,et al.  Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis , 1984, Infection and immunity.

[117]  J. Scott,et al.  Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. , 1980, Annals of the rheumatic diseases.

[118]  N. Ilbäck,et al.  Cholesterol uptake in the mouse aorta increases during Chlamydia pneumoniae infection , 2017, Pathogens and disease.

[119]  R. Inman,et al.  Chlamydia-induced ReA: immune imbalances and persistent pathogens , 2012, Nature Reviews Rheumatology.

[120]  D. Virok,et al.  Chlamydial IFN-gamma immune evasion is linked to host infection tropism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D. Scott,et al.  Arthritis associated with venereal disease in nineteenth century London , 2005, Clinical Rheumatology.

[122]  Journal of Neuroinflammation BioMed Central Review Involvement of β-chemokines in the development of inflammatory demyelination , 2005 .

[123]  D. Virok,et al.  Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  H. L. Von,et al.  Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. , 2002, The European respiratory journal.

[125]  J. Pearce,et al.  Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. , 1996, The Journal of rheumatology.

[126]  U. Yli-Kerttula,et al.  Chlamydial isolations and serology in Reiter's syndrome. , 1981, Scandinavian journal of rheumatology.